⏳ Final hours! Save up to 60% OFF InvestingProCLAIM SALE

Zimmer Biomet Holdings Inc (ZBH)

NYSE
Currency in USD
110.62
-0.12(-0.11%)
Closed
After Hours
110.620.00(0.00%)
ZBH Scorecard
Full Analysis
Management has been aggressively buying back shares
Fair Value
Day's Range
110.34111.98
52 wk Range
101.47133.90
Key Statistics
Edit
Prev. Close
110.74
Open
110.52
Day's Range
110.34-111.98
52 wk Range
101.47-133.9
Volume
1.09M
Average Volume (3m)
1.58M
1-Year Change
-5.26%
Book Value / Share
unlockUnlock
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
ZBH Scorecardpro icon
Company’s Health
pro lockUnlock
Fair Value
pro lockUnlock Price
Fair Pricepro lock
Upsidepro lock
Price Target
124.65
Upside
+12.68%
Members' Sentiments
Bearish
Bullish
ProTips
16 analysts have revised their earnings upwards for the upcoming period
Show more

Zimmer Biomet Holdings Inc Company Profile

Zimmer Biomet Holdings, Inc., together with its subsidiaries, operates as a medical technology company worldwide. The company designs, manufactures, and markets orthopedic reconstructive products, such as knee and hip products; S.E.T. products, including sports medicine, biologics, foot and ankle, extremities, and trauma products; craniomaxillofacial and thoracic products comprising face and skull reconstruction products, as well as products that fixate and stabilize the bones of the chest to facilitate healing or reconstruction after open heart surgery, trauma, or for deformities of the chest. It also offers robotic, surgical, and bone cement products. The company’s products and solutions are used to treat patients suffering from disorders of, or injuries to, bones, joints, or supporting soft tissues. It serves orthopedic surgeons, neurosurgeons, hospitals, stocking distributors, healthcare dealers, and other specialists, as well as agents, healthcare purchasing organizations, or buying groups. The company was formerly known as Zimmer Holdings, Inc. and changed its name to Zimmer Biomet Holdings, Inc. in June 2015. Zimmer Biomet Holdings, Inc. was founded in 1927 and is headquartered in Warsaw, Indiana.

Zimmer Biomet Holdings Inc SWOT Analysis


Ambitious Growth Plan
Zimmer Biomet's Long Range Plan aims to outpace market growth, expand margins, and drive EPS growth, setting ambitious targets for 2024-2027
ERP Hurdles
Explore the challenges Zimmer Biomet faces with its ERP system transition, potentially impacting revenue by 1% and testing operational resilience
M&A-Driven Expansion
Learn about Zimmer Biomet's $5-6 billion M&A budget, a key strategy for portfolio expansion and market penetration in the medical device industry
Analyst Perspectives
Analysts offer mixed views on Zimmer Biomet's outlook, with price targets ranging from $125 to $140, reflecting both optimism and caution
Read full SWOT analysis
ZBH Full Pro Research
Institutional-Grade Stock Analysis
Understand how ZBH earns money
Financial health at a glance
Bearish and bullish outlooks
Latest expert insights
Actionable Pro Tips, and many more...
Gain access to 1400+ in-depth research reports on the most popular US stocks

Zimmer Biomet Holdings Inc Earnings Call Summary for Q4/2024

  • Net sales up 4% to $1.824B, adjusted EPS rises to $1.74; full-year revenue growth projection adjusted to 4.25%-4.75% in constant currency
  • ERP challenges impact reduced to 60-80 basis points from 100; normal shipping levels expected by end of 2024
  • Over 50 product launches planned, including Z1 hip system and Persona IQ knee technology; $600M in shares repurchased in Q3
  • Mid-single-digit growth in knee and hip segments; S.E.T. segment up 7.3% for fourth consecutive quarter
  • Management optimistic about overcoming ERP issues, continuing mid-single-digit revenue growth streak into 11th consecutive quarter
Last Updated: 10/31/2024, 02:44 AM
Read Full Transcript

Compare ZBH to Peers and Sector

Metrics to compare
ZBH
Peers
Sector
Relationship
P/E Ratio
20.3x−8.4x−0.7x
PEG Ratio
0.150.020.00
Price/Book
1.8x4.2x2.6x
Price / LTM Sales
2.9x2.9x3.2x
Upside (Analyst Target)
12.0%36.2%46.4%
Fair Value Upside
Unlock4.3%6.9%Unlock

Analysts' Recommendations

10 Buy
18 Hold
2 Sell
Ratings:
26 analysts
Overall Consensus
Neutral

Analysts 12-Month Price Target:

Average 124.65

(+12.68% Upside)

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 5.28
Dividend Yield
0.87%
Industry Median 0.73%
Annualized payout
0.9600
Paid quarterly
5-Years Growth
-
Growth Streak

People Also Watch

160.99
BIIB
+0.09%
41.81
SMCI
+3.98%
261.78
TRV
+0.46%

FAQ

What Is the Zimmer Biomet (ZBH) Stock Price Today?

The Zimmer Biomet stock price today is 110.62

What Stock Exchange Does Zimmer Biomet Trade On?

Zimmer Biomet is listed and trades on the NYSE stock exchange.

What Is the Stock Symbol for Zimmer Biomet?

The stock symbol for Zimmer Biomet is "ZBH."

Does Zimmer Biomet Pay Dividends? What’s The Current Dividend Yield?

The Zimmer Biomet dividend yield is 0.87%.

What Is the Zimmer Biomet Market Cap?

As of today, Zimmer Biomet market cap is 22.04B.

What is Zimmer Biomet Earnings Per Share?

The Zimmer Biomet EPS is 5.28.

What Is the Next Zimmer Biomet Earnings Date?

Zimmer Biomet will release its next earnings report on Feb 04, 2025.

From a Technical Analysis Perspective, Is ZBH a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Neutral.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.